[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
Hug
J
J
Abteilung Innere Medizin III, Kardiologie, Medizinische Universitätklinik Freiburg.
Hasenfuss
G
G
Wollschläger
H
H
Just
H J
HJ
Bonzel
T
T
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D014665:Vasodilator Agents; C002385:linsidomine; D008981:Molsidomine
Koronardilatation nach intrakoronar verabreichtem SIN-1 bzw. intravenöser Molsidomin-Gabe.